losartan has been researched along with Animal Mammary Carcinoma in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vinson, GP | 1 |
| Cun, X | 1 |
| Ruan, S | 1 |
| Chen, J | 1 |
| Zhang, L | 1 |
| Li, J | 1 |
| He, Q | 1 |
| Gao, H | 1 |
2 other studies available for losartan and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Why isn't the angiotensin type 1 receptor a target in cancer?
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Humans; Losartan; Mammary Neoplasms, Animal; Recep | 2017 |
A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan.
Topics: Animals; Cell Line, Tumor; Cell Survival; Collagen; Extracellular Matrix; Female; Gene Expression Re | 2016 |